Minimum inhibitory concentrations of various antifungal agents against Basidiomycetes clinical isolates
Arzumanian, V.G.
Antibiotiki i Khimioterapiia 47(2): 7-10
2002
ISSN/ISBN: 0235-2990 PMID: 12087724 Document Number: 548986
The basidiomycete yeasts are often isolated from clinical samples. A minimal inhibiting concentrations (MIC) of ten antifungals of different groups--azols, allilamines, polyens etc.--against isolates of Rhodotorula, Cryptococcus [symbol: see text] Trichosporon yeasts genera were estimated. No one of these cultures was sensitive to azoles at concentrations 0-256 mcg/ml. A vitality of cultures after incubation during 10 days with antifungals was investigated. Miramistin was the most potent fungicidal agent against all cultures.
Document emailed within 1 workday
Related Documents
Powers, T.E.; Varma, K.J.; Powers, J.D. 1984: Selecting therapeutic concentrations: minimum inhibitory concentrations vs subminimum or supraminimum inhibitory concentrations Journal of the American Veterinary Medical Association 185(10): 1062-1067Yamane, N.; Onaga, S.; Saitoh, H.; Toyoshima, S.; Shimojima, M.; Kawahara, S.; Takashima, T.; Yamashita, T. 2002: Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria Rinsho Byori. Japanese Journal of Clinical Pathology 50(4): 381-391
Linares, M.J.; Muñoz, J.F.; Solís, F.; Rodríguez, F.C.; Valero, A.; Casal, M. 1998: Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the e test Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 11(1): 64-69
Otaya, H.; Kuraoka, Y. 1975: The correlation between the clinical effectiveness and ratio of blood concentration to minimum inhibitory concentration of sulfamethoxazole against Escherichia coli isolates. the determination of a parameter in a dosage equation by the pharmacokinetics International Journal of Clinical Pharmacology and Biopharmacy 12(4): 395-402
Uchida, K.; Hosaka, J.; Aoki, K.; Yamaguchi, H. 1991: In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses Japanese Journal of Antibiotics 44(5): 571-579
Igari, J.; Watanabe, N.; Uehara, N.; Inoue, M.; Yoshida, H.; Imafuku, Y.; Nishino, T.; Shibano, T.; Satou, S.; Kobayashi, I.; Takahashi, A.; Yomoda, S.; Matsuoka, K.; Oguri, T.; Ohba, Y.; Kumasaka, K.; Tokuda, K.; Kobayashi, Y.; Hongo, T.; Okada, J.; Sasaki, T.; Matsumoto, N.; Hirata, Y.; Nakasaki, N.; Ono, J.; Takata, T.; Kawaguchi, R.; Ohtaki, Y.; Kajimura, K.; Ishigo, S.; Hashimoto, T.; Aoki, N.; Okamoto, E.; Murakami, E.; Saeki, H. 2000: Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents Japanese Journal of Antibiotics 53(3): 157-170
Kuti, J.L.; Nicasio, A.M.; Sutherland, C.A.; Nicolau, D.P. 2009: Elevated vancomycin minimum inhibitory concentrations among methicillin-resistant Staphylococcus aureus isolated from patients with ventilator-associated pneumonia at a Connecticut hospital Connecticut Medicine 73(6): 337-340
Sasatsu, M.; Miyazawa, K.; Noguchi, N.; Kono, M. 1994: Effect of beta-lactamase on minimum inhibitory concentrations of methicillin in methicillin-resistant Staphylococcus aureus Microbios 78(316): 145-153
Urbanowski, S.; Nierebińska, E.; Gwieździński, Z. 1989: Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans Przeglad Dermatologiczny 76(5-6): 405-409
Igari, J. 1990: Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Reported by the Research Group for Testing Imipenem Susceptibility on Clinical Isolates Japanese Journal of Antibiotics 43(11): 1956-2002
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Paramasivan, C.N.; Venkataraman, P.; Herbert, D. 1997: Minimal inhibitory concentrations of sulbactam/ampicillin against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis Microbios 89: 360-361
Zhao, M.; Zhou, Z.-t. 2006: Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida Shanghai Kou Qiang Yi Xue 15(2): 218-220
Silvestri, R.; Pagnozzi, E.; Troccoli, F.; Stefancich, G.; Massa, S.; Apuzzo, G.; Perazzi, M.E.; Artico, M.; Simonetti, G. 1995: Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives Farmaco 50(4): 227-238
Massa, S.; Stefancich, G.; Corelli, F.; Silvestri, R.; Panico, S.; Artico, M.; Simonetti, N. 1988: Researches on antibacterial and antifungal agents. IX--Pyrrole analogues of bifonazole with potent antifungal activities Il Farmaco; Edizione Scientifica 43(9): 693-704
Breckenridge, A. 1992: Clinical significance of interactions with antifungal agents British Journal of Dermatology 126(Suppl): 19-22
Shah, D.T.; Walker, E.M.; Jones, M.M.; Singh, P.K.; Larsen, B. 1997: Inhibitory effects of seven organosulphur compounds on clinical isolates of Candida species in vitro Annals of Clinical and Laboratory Science 27(4): 282-286
Manyi-Loh, C.E.; Clarke, A.M.; Green, E.; Ndip, R.N. 2013: Inhibitory and bactericidal activity of selected South African honeys and their solvent extracts against clinical isolates of Helicobacter pylori Pakistan Journal of Pharmaceutical Sciences 26(5): 897-906
Jacobs, M.R. 2005: Antimicrobial Agents and Resistance--Fifth International Symposium. Antifungal agents and novel vaccines IDrugs: the investigational drugs journal 8(7): 547-550
Igari, J.; Inoue, M.; Nishino, T.; Watanabe, N.; Uehara, N.; Yoshida, H.; Imafuku, Y.; Shibano, T.; Satou, S.; Kobayashi, I.; Takahashi, A.; Yomoda, S.; Oguri, T.; Kumasaka, K.; Kobayasi, Y.; Okada, J.; Hirata, Y.; Nakasaki, N.; Kawaguchi, R.; Ohtaki, Y.; Ishigo, S.; Okamoto, E.; Murakami, E.; Matsuoka, K.; Saeki, H. 1998: Survey of the sensitivities of clinical isolates to antibacterial agents (annual report) Japanese Journal of Antibiotics 51(2): 47-68